Concepedia

Aksana K. Jones

AK

Statistics

Publications

10

Citations

354

H-Index

10

Active since

1989

Affiliations

AbbVie (United States)(Current)

Ain Shams University

Indivior (United States)

Simulations Plus (United States)

Aksana K. Jones is an author at AbbVie (United States) specializing in hematology, medicine, and oncology.

ORCID

Top concepts

Publications per year

1989–2022

10

Publications

10

Clinical Predictors of Venetoclax Pharmacokinetics in Chronic Lymphocytic Leukemia and Non-Hodgkin’s Lymphoma Patients: a Pooled Population Pharmacokinetic Analysis

Aksana K. Jones, Kevin J. Freise, Suresh Agarwal et al. · The AAPS Journal · 2016 · 99 citations

, , +9

Impact of Venetoclax Exposure on Clinical Efficacy and Safety in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia

Kevin J. Freise, Aksana K. Jones, Doerthe Eckert et al. · Clinical Pharmacokinetics · 2016 · 61 citations

, , +7

Population Pharmacokinetics of a Monthly Buprenorphine Depot Injection for the Treatment of Opioid Use Disorder: A Combined Analysis of Phase II and Phase III Trials

Aksana K. Jones, Eliford Ngaimisi, Mathangi Gopalakrishnan et al. · Clinical Pharmacokinetics · 2020 · 48 citations · Full text

Relationship between venetoclax exposure, rituximab coadministration, and progression‐free survival in patients with relapsed or refractory chronic lymphocytic leukemia: demonstration of synergy

Kevin J. Freise, Aksana K. Jones, Rajeev Menon et al. · Hematological Oncology · 2016 · 42 citations

Moving Beyond Maximum Tolerated Dose for Targeted Oncology Drugs: Use of Clinical Utility Index to Optimize Venetoclax Dosage in Multiple Myeloma Patients

KJ Freise, Aksana K. Jones, M.E. Verdugo et al. · Clinical Pharmacology & Therapeutics · 2017 · 34 citations

, , +18

1–5 of 10